OxiGene (OXGN)

Add to Watchlists Create an Alert
3.31 +0.03  +0.91%   NASDAQ May 23, 8:00PM BATS Real time Currency in USD

OxiGene News

OXiGENE Management Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 6

OXiGENE Management Discusses Q1 2013 Results - Earnings Call Transcript

OXiGENE Reports First Quarter 2013 Financial Results
GlobeNewswire May 6

SOUTH SAN FRANCISCO, Calif. -- OXiGENE, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, reported financial results for the quarter ended March 31, 2013....

OXiGENE Announces Completion of Enrollment of ZYBRESTAT(R) Phase 2 Ovarian Cancer Trial
noodls Apr 24

SOUTH SAN FRANCISCO, Calif., April 24, 2013 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced that enrollment ...

OXiGENE Announces First Quarter 2013 Earnings Conference Call and Webcast
noodls Apr 24

SOUTH SAN FRANCISCO, Calif., April 24, 2013 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, will report first ...

Get News for

Recent Quotes

Symbol Price Chg Chg % Market Cap
OXGN 3.31 +0.03 +0.91% 7.197M
New watchlist
Create
Success.

Your new watchlist has been created

View WatchlistsDone
Create Watchlist from Quotes

Register for your Free YCharts Account.

Understand your investments with more data than any other free site.

  • Create watchlists that you care about for stocks or economic indicators
  • Create alerts to track the movements of your stocks
  • Access stock analysis from our in-house experts
Get Started Now

Already registered? Sign in to your account.

document.write('');